These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

407 related items for PubMed ID: 26141264

  • 1. [(18)F]flutemetamol amyloid positron emission tomography in preclinical and symptomatic Alzheimer's disease: specific detection of advanced phases of amyloid-β pathology.
    Thal DR, Beach TG, Zanette M, Heurling K, Chakrabarty A, Ismail A, Smith AP, Buckley C.
    Alzheimers Dement; 2015 Aug; 11(8):975-85. PubMed ID: 26141264
    [Abstract] [Full Text] [Related]

  • 2. Post-mortem histopathology underlying β-amyloid PET imaging following flutemetamol F 18 injection.
    Ikonomovic MD, Buckley CJ, Heurling K, Sherwin P, Jones PA, Zanette M, Mathis CA, Klunk WE, Chakrabarty A, Ironside J, Ismail A, Smith C, Thal DR, Beach TG, Farrar G, Smith AP.
    Acta Neuropathol Commun; 2016 Dec 12; 4(1):130. PubMed ID: 27955679
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Estimation of amyloid distribution by [18F]flutemetamol PET predicts the neuropathological phase of amyloid β-protein deposition.
    Thal DR, Beach TG, Zanette M, Lilja J, Heurling K, Chakrabarty A, Ismail A, Farrar G, Buckley C, Smith APL.
    Acta Neuropathol; 2018 Oct 12; 136(4):557-567. PubMed ID: 30123935
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [(18)F]Flutemetamol PET imaging and cortical biopsy histopathology for fibrillar amyloid β detection in living subjects with normal pressure hydrocephalus: pooled analysis of four studies.
    Rinne JO, Wong DF, Wolk DA, Leinonen V, Arnold SE, Buckley C, Smith A, McLain R, Sherwin PF, Farrar G, Kailajärvi M, Grachev ID.
    Acta Neuropathol; 2012 Dec 12; 124(6):833-45. PubMed ID: 23053137
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. 18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
    Martínez G, Vernooij RW, Fuentes Padilla P, Zamora J, Flicker L, Bonfill Cosp X.
    Cochrane Database Syst Rev; 2017 Nov 22; 11(11):CD012884. PubMed ID: 29164602
    [Abstract] [Full Text] [Related]

  • 10. Imaging β-amyloid using [(18)F]flutemetamol positron emission tomography: from dosimetry to clinical diagnosis.
    Heurling K, Leuzy A, Zimmer ER, Lubberink M, Nordberg A.
    Eur J Nucl Med Mol Imaging; 2016 Feb 22; 43(2):362-373. PubMed ID: 26440450
    [Abstract] [Full Text] [Related]

  • 11. Different aspects of Alzheimer's disease-related amyloid β-peptide pathology and their relationship to amyloid positron emission tomography imaging and dementia.
    Thal DR, Ronisz A, Tousseyn T, Rijal Upadhaya A, Balakrishnan K, Vandenberghe R, Vandenbulcke M, von Arnim CAF, Otto M, Beach TG, Lilja J, Heurling K, Chakrabarty A, Ismail A, Buckley C, Smith APL, Kumar S, Farrar G, Walter J.
    Acta Neuropathol Commun; 2019 Nov 14; 7(1):178. PubMed ID: 31727169
    [Abstract] [Full Text] [Related]

  • 12. Detection of Striatal Amyloid Plaques with [18F]flutemetamol: Validation with Postmortem Histopathology.
    Beach TG, Thal DR, Zanette M, Smith A, Buckley C.
    J Alzheimers Dis; 2016 Mar 31; 52(3):863-73. PubMed ID: 27031469
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Is there a difference in regional read [18F]flutemetamol amyloid patterns between end-of-life subjects and those with amnestic mild cognitive impairment?
    Farrar G, Molinuevo JL, Zanette M.
    Eur J Nucl Med Mol Imaging; 2019 Jun 31; 46(6):1299-1308. PubMed ID: 30863934
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Automated semi-quantitative amyloid PET analysis technique without MR images for Alzheimer's disease.
    Imabayashi E, Tamamura N, Yamaguchi Y, Kamitaka Y, Sakata M, Ishii K.
    Ann Nucl Med; 2022 Oct 31; 36(10):865-875. PubMed ID: 35821311
    [Abstract] [Full Text] [Related]

  • 19. Diagnostic effectiveness of quantitative [¹⁸F]flutemetamol PET imaging for detection of fibrillar amyloid β using cortical biopsy histopathology as the standard of truth in subjects with idiopathic normal pressure hydrocephalus.
    Leinonen V, Rinne JO, Wong DF, Wolk DA, Trojanowski JQ, Sherwin PF, Smith A, Heurling K, Su M, Grachev ID.
    Acta Neuropathol Commun; 2014 Apr 22; 2():46. PubMed ID: 24755237
    [Abstract] [Full Text] [Related]

  • 20. Clinical impact of [18F]flutemetamol PET among memory clinic patients with an unclear diagnosis.
    Leuzy A, Savitcheva I, Chiotis K, Lilja J, Andersen P, Bogdanovic N, Jelic V, Nordberg A.
    Eur J Nucl Med Mol Imaging; 2019 Jun 22; 46(6):1276-1286. PubMed ID: 30915522
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.